Erythropoietin and the incidence of necrotizing enterocolitis in infants with very low birth weight

Journal of Pediatric Surgery

Volumn 35, Issue 2, 2000, Pages 178-182

  Ledbetter, Daniel J ^a   Juul, Sandra E ^b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

Erythropoietin; Necrotizing enterocolitis; Prematurity

Indexed keywords

ERYTHROPOIETIN RECEPTOR; RECOMBINANT ERYTHROPOIETIN;

ANEMIA; APGAR SCORE; CONFERENCE PAPER; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NECROTIZING ENTEROCOLITIS; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; SEX DIFFERENCE; VERY LOW BIRTH WEIGHT;

EID: 0033961152     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3468(00)90006-X     Document Type: Conference Paper

References (25)

1. Kliegman RM, Walsh MC: Neonatal necrotizing enterocolitis: Pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 17:213-288, 1987
2. Stoll BJ: Epidemiology of necrotizing enterocolitis. Clin Perinatol 21:205-218, 1994
3. Lucas A, Cole TJ: Breast milk and neonatal necrotising enterocolitis. Lancet 336:1519-1523, 1990
4. Buescher ES: Host defense mechanisms of human milk and their relations to enteric infections and necrotizing enterocolitis. Clin Perinatol 21:247-262, 1994
5. Maier RF, Obladen M, Scigalla P, et al: The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 330:1173-1178, 1994
6. Kling PJ, Sullivan TM, Roberts RA, et al: Human milk as a potential enterai source of erythropoietin. Pediatr Res 43:216-221, 1998
7. Juul SE, Yachnis AT, Rojiani AM, et al: The tissue distribution of Epo and Epo-R in the developing human fetus. Early Hum Dev 52:235-249, 1998
8. Juul SE, Joyce AE, Zhao Y, et al: Why is erythropoietin present in breast milk? Studies of erythropoietin receptors on enterocytes of human and rat neonates. Pediatr Res 46:263-268, 1999
9. Bell MJ, Ternberg JL, Feigin RD, et al: Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg 187:1-7, 1978
10. Ohls RK, Osborne KA, Christensen RD: Efficacy and cost analysis of treating very low birth weight infants with erythropoietin during their first two weeks of life: a randomized, placebo-controlled trial. J Pediatr 126:421-426, 1995
11. Ohls RK, Veerman MW, Christensen RD: Pharmacokinetics and effectiveness of recombinant erythropoietin administered to preterm infants by continuous infusion in total parenteral nutrition solution. J Pediatr 128:518-523, 1996
12. Kosloske AM: A unifying hypothesis for pathogenesis and prevention of necrotizing enterocolitis. J Pediatr 117:S68-74, 1990
13. Bauer CR, Morrison JC, Poole WK, et al: A decreased incidence of necrotizing enterocolitis after prenatal glucocorticoid therapy. Pediatrics 73:682-688, 1984
14. Halac E, Halac J, Begue EF, et al: Prenatal and postnatal corticosteroid therapy to prevent neonatal necrotizing enterocolitis: A controlled trial. J Pediatr 117:132-138, 1990
15. Eibl MM, Wolf HM, Furnkranz H, et al: Prevention of necrotizing enterocolitis in low-birth-weight infants by IgA-IgG feeding. N Engl J Med 319:1-7, 1988
16. Richter D, Bartmann P, Pohlandt F: Prevention of necrotizing enterocolitis in extremely low birth weight infants by IgG feeding? Eur J Pediatr 157:924-925, 1998
17. Anagnostou A, Liu Z, Steiner M, et al: Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 91:3974-3978, 1994
18. Juul SE, Anderson DK, Li Y, et al: Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr Res 43:40-49, 1998
19. Wald MR, Borda ES, Sterin-Borda L: Mitogenic effect of erythropoietin on neonatal rat cardiomyocytes: Signal transduction pathways. J Cell Physiol 167:461-468, 1996
20. Lorentz A, Eckardt KU, Osswald PM, et al: Erythropoietin levels in patients depositing autologous blood in short intervals. Ann Hematol 64:281-285, 1992
21. Uauy RD, Fanaroff AA, Korones SB, et al: Necrotizing enterocolitis in very low birth weight infants: Biodemographic and clinical correlates. National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr 119:630-638, 1991
22. Asch J, Wedgwood JF: Optimizing the approach to anemia in the preterm infant: Is there a role for erythropoietin therapy? J Perinatol 17:276-282, 1997
23. Bifano EM, Curran TR: Minimizing donor blood exposure in the neonatal intensive care unit. Current trends and future prospects. Clin Perinatol 22:657-669, 1995
24. Van Bel F, Van Zoeren D, Schipper J, et al: Effect of indomethacin on superior inesenteric artery blood flow velocity in preterm infants. J Pediatr 116:965-970, 1990
25. Gersony WM, Peckham GJ, Ellison RC, et al: Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative study. J Pediatr 102:895-906, 1983